Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatic synthesis of very low-density lipoprotein (VLDL) refers to the process by which liver cells (hepatocytes) assemble and secrete VLDL particles into the bloodstream. VLDLs are a class of lipoproteins primarily responsible for transporting endogenous triglycerides, cholesterol, and other lipids from the liver to peripheral tissues. This process is central to lipid metabolism and plays a significant role in both normal physiology and metabolic diseases.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatic Synthesis of Very Low-Density Lipoprotein (Hepatic VLDL Synthesis).